Cell Differentiation and Stem Cells: Principles of Genetics and Development
Fundamentals of Cell Differentiation and Gene Expression
Core Question of Development: If all cells within an organism possess the identical DNA, how do they become distinct in form and function?
Differential Gene Expression: The mechanism behind cell variety is the selective expression of genes.
Regulatory Transcription Factors (RTFs): These are the primary drivers of differentiation, controlling which genes are turned on or off.
Process Overview: Cellular development involves a transition from unspecialized to specialized states. - This process begins in the embryo. - It continues throughout the lifespan, into birth and adulthood.
Combinatorial Control (Figure 8.2): A small number of genes, when expressed in different combinations, can specify a vast array of different cell types. For example, if genes are labeled $X$, $Y$, and $Z$, different combinations of these three can result in distinct cellular identities.
Identifiable Differentiated Cells (Figure 8.1): Differentiation results in cells with distinct identities and functions, including: - Fat cells - Epithelial cells - Nerve cells - Olfactory neurons - Red blood cells - Retinal rods
Theoretical Models of Development
Mosaic Development: - Characterized as unregulated or uncontrolled development. - Cell fates are pre-determined based on their lineage and position.
Regulative Development: - If a portion of the embryo is missing or removed, the embryo can regulate and restore normal development. - Sea Urchin Experiment: When cells are separated at the -cell stage, each cell is capable of developing into a complete, normal embryo.
Extracellular Triggers: Differentiation is often triggered by signals from outside the cell. - Surface Receptors: Bind to external signaling molecules. - Intracellular Receptors: Utilized by signaling molecules like steroid hormones that can cross the cell membrane.
Levels of Cellular Commitment
1. Specified (Less Committed): - The cell has received instructions for a specific fate. - It does not have to follow these instructions yet. - It can still be influenced by its environment. - In this state, developmental potential is greater than the actual fate (\text{potential} > \text{fate}).
2. Determined (More Committed): - The cell has received instructions and must follow them; it cannot change. - It can no longer be influenced by the environment to change its fate. - In this state, potential equals fate ().
3. Differentiated (Final State): - The cell reaches its final functional form (fate).
Characteristics of Terminal Differentiation
Terminally Differentiated Cells: These represent a stable final state where mitosis (cell division) no longer occurs.
Structural Changes: Significant physical alterations occur to reflect the cell's specialized function.
Examples of Differentiated Features: - Red Blood Cells (RBCs): - Loss of the nucleus. - Adoption of a biconcave disc shape. - Production of hemoglobin. - Neutrophils (White Blood Cells/WBCs): - Characterized by a multilobed nucleus. - Presence of secretory granules.
Case Study: Hematopoietic Stem Cells (HSCs) and Blood Differentiation
HSCs (Figure 8.13): Located in the bone marrow, which serves as their niche.
Stem Cell Hallmarks: - Multipotent: Can differentiate into several types of blood cells (RBCs and WBCs). - Self-renewal: Capability to divide and produce more stem cells.
Case Study: Muscle Differentiation and the MyoD Regulator
Master Regulator: MyoD is the regulatory transcription factor (RTF) required for muscle differentiation (Figure 8.6). - Necessary: If MyoD is mutated, no muscle forms. - Sufficient: Ectopic expression of MyoD in non-muscle cells can convert them into muscle cells.
Path to Muscle Formation (Figure 8.11): - Somites $\rightarrow$ Myoblasts $\rightarrow$ Muscle. - Pax3 and Pax7: Homeodomain transcription factors involved in the process. - Myoblasts: These are committed but still undifferentiated cells that divide.
Differentiation Steps: - Myoblasts stop dividing. - They begin producing muscle-specific proteins. - Structural changes occur. - Cells fuse to form myotubes, which then become muscle fibers.
Muscle Stem Cells (Satellite Cells): - These are associated with muscle fibers. - Niche: The microenvironment interacting with these stem cells to determine their fate (Figure 8.26). - Regeneration: Injury to the muscle activates satellite cells to regenerate tissue.
Differentiation Niche: Skin and Gut
Epithelial Regeneration: - Both skin epidermis and the gut lining are harsh environments requiring constant regeneration. - Gut lining regenerates every days (Figure 8.23).
Regulatory Signaling (Figures 8.20, 8.23, 8.25): - Wnt: Promotes stem cell division (active during injury or normal turnover). - BMP: Inhibits stem cell division (active when there is no injury).
The Crypt: The specific stem cell niche located in the gut (Figure 8.23).
Stem Cell Division and Potency
Asymmetric Division (Figure 8.22): A single stem cell divides to produce one identical stem cell (self-renewal) and one progenitor cell. Progenitors then give rise to differentiated cells.
Adult Stem Cells (ASCs): - Potency: Multipotent (limited to certain lineages). - Examples: HSCs (blood), Satellite cells (muscle), Gut stem cells (gut). - Requirement: Always require a specific niche.
Embryonic Stem Cells (ESCs): - Potency: Pluripotent (not limited; can form all three germ layers). - Source: Inner Cell Mass (ICM) of a blastocyst. - Niche: Do not require a niche.
Mouse Embryo Markers ( days): - Nanog: Marker for the ICM. - Gata6 and Cdx2: Markers for other layers.
Comparative Analysis: ESCs, epiSCs, and Human ESCs
Mouse ESCs (Figure 8.34): - Can self-renew in vitro indefinitely without a niche. - Pluripotent: If injected into a blastocyst, they contribute to a chimera (all three germ layers). - Used for disease models and drug screening.
Mouse Epiblast Stem Cells (epiSCs): - Derived from -day-old embryos. - Pluripotent but different from ESCs. - Limitation: Cannot form chimeras.
Human ESCs (Discovered ): - Share the same RTFs as mouse ESCs (Nanog, Oct4, Sox2, Kfl4). - Culture Maintenance: Require FGF + Nodal (unlike mouse ESCs which use LIF). - Differentiation: Stimulated by BMP (unlike mouse ESCs). - Comparison: Human ESCs are more similar to mouse epiSCs than to mouse ESCs.
Differentiated Cell Plasticity and Reprogramming
Dedifferentiation: A cell loses its differentiated characteristics to go "backwards" and become a stem-like cell that can divide.
Transdifferentiation: A cell converts directly from one differentiated cell type to another without becoming a stem cell first.
Somatic Cell Nuclear Transfer (SCNT) / Cloning (Figures 8.29, 8.30): - An adult nucleus is transferred into an egg to support embryonic development. - Genomic Equivalence: Proves adult nuclei have all genes necessary to build a new embryo. - Efficiency Rates: - Adult Nucleus: Low efficiency. - Tadpole Nucleus: High efficiency. - Blastocyst Nucleus: Very high efficiency.
Reprogramming by Cell Fusion (Figure 8.31): - Fusing two cells (e.g., human liver and mouse muscle) creates a tetraploid cell with a common cytoplasm. - Cytoplasmic factors from the muscle cell can reprogram the liver cell to express muscle-specific genes.
Regenerative Medicine and iPSCs
Regenerative Medicine Goals (Figure 8.33): - To replace damaged tissue or organs. - To solve organ donation shortages (e.g., year waits for kidneys) and avoid rejection issues requiring immunosuppressive drugs.
Comparison of Approaches: - ESCs: - Pros: Pluripotent. - Cons: Tumor risk (teratomas), ethical concerns, rejection risk (not the patient's own DNA). - ASCs: - Pros: No rejection if autologous (from self). - Cons: Not pluripotent (limited application).
Induced Pluripotent Stem Cells (iPSCs): - Discovery: . - Method: Skin cells are transfected with specific genes: Oct4, Sox2, Kfl4, and c-Myc. - Nobel Prize: Awarded in (shared with frog cloning research). - Function: Equivalent to ESCs; capable of self-renewal and forming chimeras.
Application: Type 1 Diabetes (Figure 8.35): - The pancreas lacks stem cells to replace destroyed -cells. - Therapy involves using ESCs, iPSCs, or transdifferentiation (e.g., from liver cells or exocrine pancreas cells using the factor Pdx1) to create insulin-producing, glucose-responsive cells.